211 related articles for article (PubMed ID: 22761740)
1. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.
Kotelevets N; Fabbro D; Huwiler A; Zangemeister-Wittke U
PLoS One; 2012; 7(6):e39209. PubMed ID: 22761740
[TBL] [Abstract][Full Text] [Related]
2. Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage.
Huwiler A; Kotelevets N; Xin C; Pastukhov O; Pfeilschifter J; Zangemeister-Wittke U
Br J Pharmacol; 2011 Jan; 162(2):532-43. PubMed ID: 20883472
[TBL] [Abstract][Full Text] [Related]
3. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA).
Johnson KR; Becker KP; Facchinetti MM; Hannun YA; Obeid LM
J Biol Chem; 2002 Sep; 277(38):35257-62. PubMed ID: 12124383
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
5. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.
Zhao Y; Kalari SK; Usatyuk PV; Gorshkova I; He D; Watkins T; Brindley DN; Sun C; Bittman R; Garcia JG; Berdyshev EV; Natarajan V
J Biol Chem; 2007 May; 282(19):14165-77. PubMed ID: 17379599
[TBL] [Abstract][Full Text] [Related]
6. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
7. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of sphingosine kinase inhibitors.
French KJ; Upson JJ; Keller SN; Zhuang Y; Yun JK; Smith CD
J Pharmacol Exp Ther; 2006 Aug; 318(2):596-603. PubMed ID: 16632640
[TBL] [Abstract][Full Text] [Related]
9. The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7.
Döll F; Pfeilschifter J; Huwiler A
Biochim Biophys Acta; 2005 Dec; 1738(1-3):72-81. PubMed ID: 16414307
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
12. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells.
Böhm A; Flößer A; Ermler S; Fender AC; Lüth A; Kleuser B; Schrör K; Rauch BH
Cardiovasc Res; 2013 Aug; 99(3):505-13. PubMed ID: 23658376
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation.
El-Shewy HM; Abdel-Samie SA; Al Qalam AM; Lee MH; Kitatani K; Anelli V; Jaffa AA; Obeid LM; Luttrell LM
Mol Endocrinol; 2011 Dec; 25(12):2144-56. PubMed ID: 22016563
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
15. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
16. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase.
Pitson SM; Moretti PA; Zebol JR; Xia P; Gamble JR; Vadas MA; D'Andrea RJ; Wattenberg BW
J Biol Chem; 2000 Oct; 275(43):33945-50. PubMed ID: 10944534
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.
Bergelin N; Blom T; Heikkilä J; Löf C; Alam C; Balthasar S; Slotte JP; Hinkkanen A; Törnquist K
Endocrinology; 2009 May; 150(5):2055-63. PubMed ID: 19116345
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis.
Santacreu BJ; Pescio LG; Romero DJ; Corradi GR; Sterin-Speziale N; Favale NO
PLoS One; 2019; 14(3):e0213917. PubMed ID: 30897151
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
[TBL] [Abstract][Full Text] [Related]
20. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism.
Huwiler A; Döll F; Ren S; Klawitter S; Greening A; Römer I; Bubnova S; Reinsberg L; Pfeilschifter J
Biochim Biophys Acta; 2006 Mar; 1761(3):367-76. PubMed ID: 16571380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
